A KRAS protein bearing cysteine in place of glycine at residue 12. The introduced cysteine permits selective covalent chemistry at a suitable pocket; this strategy does not automatically apply to other Ras mutations.
A covalent inhibitor developed against KRAS G12C protein, also called sotorasib. Its state-dependent binding illustrates targeting a mutant small GTPase outside the nucleotide site.[ref]

Articles by others on the same topic (0)

There are currently no matching articles.